Your browser doesn't support javascript.
loading
The cost of multiple sclerosis drugs in the US and the pharmaceutical industry: Too big to fail?
Hartung, Daniel M; Bourdette, Dennis N; Ahmed, Sharia M; Whitham, Ruth H.
Afiliación
  • Hartung DM; From the College of Pharmacy (D.M.H., S.M.A.), Oregon State University/Oregon Health & Science University; and the Department of Neurology (D.N.B., R.H.W.), Oregon Health & Science University, Multiple Sclerosis Center of Excellence West, Veterans Affairs Medical Center, Portland. hartungd@o
  • Bourdette DN; From the College of Pharmacy (D.M.H., S.M.A.), Oregon State University/Oregon Health & Science University; and the Department of Neurology (D.N.B., R.H.W.), Oregon Health & Science University, Multiple Sclerosis Center of Excellence West, Veterans Affairs Medical Center, Portland.
  • Ahmed SM; From the College of Pharmacy (D.M.H., S.M.A.), Oregon State University/Oregon Health & Science University; and the Department of Neurology (D.N.B., R.H.W.), Oregon Health & Science University, Multiple Sclerosis Center of Excellence West, Veterans Affairs Medical Center, Portland.
  • Whitham RH; From the College of Pharmacy (D.M.H., S.M.A.), Oregon State University/Oregon Health & Science University; and the Department of Neurology (D.N.B., R.H.W.), Oregon Health & Science University, Multiple Sclerosis Center of Excellence West, Veterans Affairs Medical Center, Portland.
Neurology ; 84(21): 2185-92, 2015 May 26.
Article en En | MEDLINE | ID: mdl-25911108
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 1_ASSA2030 Problema de salud: 1_financiamento_saude Asunto principal: Factor de Necrosis Tumoral alfa / Costos y Análisis de Costo / Industria Farmacéutica / Factores Inmunológicos / Inmunosupresores / Esclerosis Múltiple Tipo de estudio: Health_economic_evaluation Límite: Humans País/Región como asunto: America do norte Idioma: En Revista: Neurology Año: 2015 Tipo del documento: Article
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 1_ASSA2030 Problema de salud: 1_financiamento_saude Asunto principal: Factor de Necrosis Tumoral alfa / Costos y Análisis de Costo / Industria Farmacéutica / Factores Inmunológicos / Inmunosupresores / Esclerosis Múltiple Tipo de estudio: Health_economic_evaluation Límite: Humans País/Región como asunto: America do norte Idioma: En Revista: Neurology Año: 2015 Tipo del documento: Article